Zhengqing Group

Hunan Zhengqing Pharmaceutical Group Co., Ltd. was founded in 1992. It ranks among the top ten in the national large and medium-sized industrial independent innovation capability industry, is a national key leading enterprise in agricultural industrialization, a national designated production enterprise for ethnic minority products during the "Twelfth Five-Year Plan" period, and one of the top 100 national enterprises in ethnic trade and the production of ethnic specialty goods.
The company has more than 130 drug approval documents and over 40 invention patents, and has led the research and development of four major product series: Zhengqing Fengtongning Series, Qingre Jiedu Granules, Lingzhi Oral Liquid, and Yuxingcao Injection. Among them, the Zhengqing Fengtongning Series is the first natural monomeric disease-modifying anti-rheumatic traditional Chinese medicine, and won the second prize of the National Science and Technology Progress Award. Zhengqing Lingzhi Oral Liquid is currently one of the few drugs in China clearly indicated for the treatment of six major symptoms caused by tumors: insomnia, fatigue, vomiting, constipation, anorexia, and depression. It is an exclusive patented new drug with a Lingzhi drug approval number. The "Zhengqing Fengtongning Rheumatism and Pain Triple Sequential Therapy" is a national traditional Chinese medicine science and technology achievement promotion project. The promotion of this project will fully implement the "one famous doctor per township and town" activity and contribute to improving the level of primary medical care.
Holding high the banner of ethnic medicine and relying on the rich Chinese medicinal material resources of the Xuefeng and Wuling Mountains, the company has established a complete industrial chain covering cultivation, scientific research, production, and sales. At the same time, under the guidance of a major brand strategy, it innovates, sets industry benchmarks, builds the Xiangxi Traditional Chinese Medicine Valley, and is committed to becoming an *excellent traditional Chinese medicine enterprise.